Submit clinical study data conducted in adults: CDSCO Panel Tells Sanofi on atopic dermatitis drug Dr. Divya Colin4 Aug 2024 6:00 PM ISTNew Delhi: Responding to the protocol amendment proposal for Amlitelimab study, the Subject Expert Committee (SEC) functional under the Central Drug...
Sanofi gets CDSCO marketing nod for RSV treatment Beyfortus in India Ruchika Sharma1 Aug 2024 5:30 PM ISTDrugmaker, Sanofi India, has received marketing authorisation approval from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus in...
Duchenne muscular dystrophy: Sanofi owned biotech company sues Sarepta Therapeutics over patent infringement Ruchika Sharma31 July 2024 4:02 PM ISTSanofi-owned biotech company Genzyme has initiated a lawsuit against competitor Sarepta Therapeutics in Delaware federal court, accusing the firm of...
Sanofi initiates voluntary recall of Allegra, Combiflam suspensions in India over contamination in some batches Ruchika Sharma23 July 2024 11:30 AM ISTFrench Multinational Pharmaceutical Company Sanofi is voluntarily initiating a precautionary recall of Allegra Suspension syrup...
Sanofi Healthcare Gets CDSCO Panel Nod to Import and Market Belumosudil Tablets Dr. Divya Colin8 July 2024 6:00 PM ISTNew Delhi: Noting an unmet medical need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO)...
GlaxoSmithKline Pharma appoints Dr Shalini Menon as Executive Vice President - Medical Affairs Ruchika Sharma5 July 2024 4:53 PM ISTMumbai: GlaxoSmithKline Pharmaceuticals Limited has appointed Dr. Shalini Menon as Executive Vice President - Medical Affairs, effective 8th...
Dupixent approved in EU as targeted therapy for COPD: Sanofi, Regeneron Pharma Ruchika Sharma3 July 2024 2:00 PM ISTParis: Sanofi and Regeneron Pharmaceuticals has announced that the European Medicines Agency (EMA) has approved Dupixent (dupilumab) as...
Sanofi plans up to USD 1.6 billion investment in Germany: Handelsblatt Ruchika Sharma2 July 2024 2:50 PM ISTFrankfurt: French pharmaceutical company, Sanofi, is close to deciding on an investment ranging between 1.3 billion euros and 1.5 billion euros...
Sanofi names Audrey Duval Derveloy as Executive Vice President, Global Head of Corporate Affairs Ruchika Sharma22 Jun 2024 12:47 PM ISTParis: Sanofi has announced the appointment of Audrey Duval Derveloy, a seasoned healthcare industry leader and Sanofi France's President as...
Lupin buys two brands from Sanofi in Europe, Canada Ruchika Sharma5 Jun 2024 3:00 PM ISTMumbai: Lupin Limited, a global pharma major, today announced that Lupin Atlantis Holdings SA, the Company's European hub...
CDSCO panel Approves Sanofi's Protocol Amendment Proposal for to study Fitusiran Dr. Divya Colin2 Jun 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved drug major...
Sanofi concludes acquisition of Inhibrx Ruchika Sharma2 Jun 2024 11:00 AM ISTParis: Sanofi has announced the completion of its acquisition of Inhibrx, Inc. The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi’s...
